Patents by Inventor Evgeni PISAREVSKY

Evgeni PISAREVSKY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POLYMERIC CONJUGATES AND USES THEREOF
    Publication number: 20230277677
    Abstract: Polymeric conjugates comprising a polymeric matrix having associated therewith an agent that down-regulates an activity or expression of a polypeptide associated with onset or progression of melanoma, and optionally and preferably, an additional agent that acts in synergy with said agent, are provided. Synthetic methodologies for preparing these conjugates and uses thereof in treating melanoma and other cancerous diseases are also provided.
    Type: Application
    Filed: April 28, 2023
    Publication date: September 7, 2023
    Applicant: Ramot at Tel-Aviv University Ltd.
    Inventors: Ronit SATCHI-FAINARO, Evgeni PISAREVSKY, Anat ELDAR-BOOCK, Dikla BEN-SHUSHAN, Yana EPSHTEIN, Anna SCOMPARIN
  • Polymeric conjugates and uses thereof
    Patent number: 11666656
    Abstract: Polymeric conjugates comprising a polymeric matrix having associated therewith an agent that down-regulates an activity or expression of a polypeptide associated with onset or progression of melanoma, and optionally and preferably, an additional agent that acts in synergy with said agent, are provided. Synthetic methodologies for preparing these conjugates and uses thereof in treating melanoma and other cancerous diseases are also provided.
    Type: Grant
    Filed: February 24, 2017
    Date of Patent: June 6, 2023
    Assignee: Ramot at Tel-Aviv University Ltd.
    Inventors: Ronit Satchi-Fainaro, Evgeni Pisarevsky, Anat Eldar-Boock, Dikla Ben-Shushan, Yana Epshtein, Anna Scomparin
  • POLYMERIC CONJUGATES AND USES THEREOF
    Publication number: 20190060477
    Abstract: Polymeric conjugates comprising a polymeric matrix having associated therewith an agent that down-regulates an activity or expression of a polypeptide associated with onset or progression of melanoma, and optionally and preferably, an additional agent that acts in synergy with said agent, are provided. Synthetic methodologies for preparing these conjugates and uses thereof in treating melanoma and other cancerous diseases are also provided.
    Type: Application
    Filed: February 24, 2017
    Publication date: February 28, 2019
    Applicant: Ramot at Tel-Aviv University Ltd.
    Inventors: Ronit SATCHI-FAINARO, Evgeni PISAREVSKY, Anat ELDAR-BOOCK, Dikla BEN-SHUSHAN, Yana EPSHTEIN, Anna SCOMPARIN